Related content

Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study

By Kilicdag Esra Bulgan   Bagis Tayfun   Zeyneloglu Hulusi B.   Tarim Ebru   Aslan Erdogan   Haydardedeoglu Bulent   Erkanli Serkan  

Human Reproduction, Vol. 20, Iss. 4, 2005-04 ,pp. : 894-899

Oxford University Press

Access to resources Recommend Favorite

Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome

By Palomba Stefano   Russo Tiziana   Orio Francesco   Falbo Angela   Manguso Francesco   Cascella Teresa   Tolino Achille   Carmina Enrico   Colao Annamaria   Zullo Fulvio  

Human Reproduction, Vol. 21, Iss. 2, 2006-02 ,pp. : 457-465

Oxford University Press

Access to resources Recommend Favorite

Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects

By Nardo L. G.   Rai R.  

Gynecological Endocrinology, Vol. 15, Iss. 5, 2001-10 ,pp. : 373-380

Informa Healthcare

Access to resources Recommend Favorite

Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance

By Nawrocka Jolanta   Starczewski Andrzej  

Gynecological Endocrinology, Vol. 23, Iss. 4, 2007-04 ,pp. : 231-237

Informa Healthcare

Access to resources Recommend Favorite

Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome

By Dahlgren E  

Human Reproduction, Vol. 13, Iss. 10, 1998-10 ,pp. : 2706-2711

Oxford University Press

Access to resources Recommend Favorite